A drug candidate for the treatment of various fibrosis, incorporating a ligand for RIG-I, a pattern recognition receptor, as the active ingredient.
Induces migration of newly generated neurons to the injured area by improving the microenvironment of injured brain tissue.
Botulinum non-toxic hemagglutinin(bHA) fragment controls E-cadherin cell-cell adhesion
Improvement of cilial dysfunction by FGFR inhibitor through ICK/MAK pathway activation.
Oral tissue-derived neural cell therapy for stroke and spinal cord injury.
Identify platinum-resistant ovarian cancer patients using EV-miRNA markers in body fluids and treat them with JAK inhibitors.
A new concept in therapeutics targeting molecules associated with vascular inflammation
Novel targets identified from genetic analysis of a model animal and patients that differ from previous therapeutic approaches
Novel target molecules of the ergosterol synthesis pathway, a critical gene for Candida
Cell membrane-derived vesicles of target bacteria can be used to develop activation products for specific enteric bacteria and antibacterial agents against biofilm-producing bacteria
About Bionauts.jp
